BIOMARIN PHARMACEUTICAL INC Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, value, employee stock purchase plan for the quarter ending 2017-09-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, value, employee stock purchase plan for the quarter ending 2016-12-31 was $5.95M.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, value, employee stock purchase plan for the quarter ending 2016-09-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, value, employee stock purchase plan for fiscal 2016 was $12.00M, a 20.50% increase from fiscal 2015.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, value, employee stock purchase plan for fiscal 2015 was $9.96M, a 14.26% increase from fiscal 2014.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, value, employee stock purchase plan for fiscal 2014 was $8.71M, a 27.42% increase from fiscal 2013.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, value, employee stock purchase plan for fiscal 2013 was $6.84M, a 24.46% increase from fiscal 2012.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | |
| 2016-12-31 | $5.95M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $12.00M 10-K · filed 2017-02-27 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | |
| 2015-12-31 | $9.96M 10-K · filed 2017-02-27 | |
| 2014-12-31 | $8.71M 10-K · filed 2017-02-27 | |
| 2013-12-31 | $6.84M 10-K · filed 2016-02-29 | |
| 2012-12-31 | $5.50M 10-K · filed 2015-03-02 | |
| 2011-12-31 | $4.41M 10-K · filed 2014-02-26 | |
| 2010-12-31 | $3.78M 10-K · filed 2013-02-26 | |
| 2009-12-31 | $3.23M 10-K · filed 2012-02-22 | |
| 2008-12-31 | $2.63M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |